Pliant Therapeutics (PLRX) Stock Chart & Stock Price History $1.57 +0.12 (+8.28%) Closing price 04:00 PM EasternExtended Trading$1.59 +0.02 (+1.27%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pliant Therapeutics Stock Price Performance The Pliant Therapeutics (PLRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 87.47%, with a year-to-date return of -88.08%. In the past month, the stock has increased 22.66%, reflecting recent market activity. As of the latest close, Pliant Therapeutics traded at $1.45 with a market cap of $89.02 million and volume of 880,729 shares. Five years ago, the stock traded at $25.48, representing a 93.84% decrease over that period. At the time, it had a market cap of $933.32 million and a volume of 41,800 shares. Receive PLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.56%1 Month Performance+22.66%3 Month Performance+4.67%Year-To-Date Performance-88.08%1 Year Performance-87.47%5 Year Performance-93.84% PLRX Stock Chart for Tuesday, July, 22, 2025 PLRX Chart by TradingView Pliant Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/22/2025$1.45$1.57+8.28%$1.58$1.442.09 million shs$96.38 million07/21/2025$1.43$1.45+1.40%$1.50$1.40880,729 shs$89.02 million07/18/2025$1.42$1.43+0.70%$1.52$1.401.17 million shs$87.79 million07/17/2025$1.34$1.42+5.97%$1.48$1.331.85 million shs$87.17 million07/16/2025$1.39$1.34-3.60%$1.42$1.321.52 million shs$82.26 million07/15/2025$1.45$1.39-4.14%$1.49$1.38834,522 shs$85.33 million07/14/2025$1.41$1.45+2.84%$1.50$1.40670,262 shs$89.02 million07/11/2025$1.40$1.41+0.71%$1.43$1.35581,363 shs$86.56 million07/10/2025$1.36$1.40+2.94%$1.42$1.33845,589 shs$85.94 million07/09/2025$1.19$1.36+14.29%$1.41$1.203.21 million shs$83.49 million Get the Latest News and Ratings for PLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/08/2025$1.18$1.19+0.85%$1.25$1.171.48 million shs$73.05 million07/07/2025$1.25$1.18-5.22%$1.26$1.17962,325 shs$72.44 million07/04/2025$1.25$1.25$1.27$1.181.12 million shs$76.43 million07/03/2025$1.20$1.25+3.75%$1.27$1.181.12 million shs$73.66 million07/02/2025$1.17$1.20+2.56%$1.25$1.161.20 million shs$73.67 million07/01/2025$1.16$1.17+0.86%$1.26$1.131.44 million shs$71.83 million06/30/2025$1.25$1.16-7.20%$1.29$1.143.09 million shs$71.21 million06/27/2025$1.30$1.25-3.85%$1.34$1.2510.87 million shs$76.74 million06/26/2025$1.38$1.30-5.80%$1.43$1.281.06 million shs$79.81 million06/25/2025$1.30$1.38+6.15%$1.42$1.251.20 million shs$84.72 million06/24/2025$1.25$1.30+4.00%$1.33$1.24569,980 shs$79.80 million06/23/2025$1.28$1.25-2.34%$1.31$1.23722,681 shs$76.74 million Related Companies BNTC Stock Price Chart GOSS Stock Price Chart CMPS Stock Price Chart PRTA Stock Price Chart ALT Stock Price Chart AURA Stock Price Chart RNAC Stock Price Chart CAPR Stock Price Chart AMRN Stock Price Chart INBX Stock Price Chart Receive PLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PLRX) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pliant Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
